Tag: Notice

Fujitsu today announced that it will raise the standard price of certain products and optional products of the FUJITSU Server PRIMERGY series in Japan as of February 2022. Amid the impact of the recent global supply shortage of semiconductors and various raw materials on parts and materials procurement, the Fujitsu Group has made every effort to secure parts and materials necessary for production. However, ongoing circumstances, including further increases in procurement and logistics costs, mean that it is no longer possible for Fujitsu to maintain supply prices by absorbing these expenses through efforts to improve production costs and reduce costs ... Read more

Commencement notice for Mercury Control Ordinance gazetted **********************************************************      The Government published in the Gazette today (August 13) the Mercury Control Ordinance (Commencement) Notice (the Commencement Notice).             The Legislative Council passed the Mercury Control Bill on June 23 to fully implement the Minamata Convention on Mercury (the Convention). The Mercury Control Ordinance (the Ordinance) regulates matters including the import, export, keeping and use of mercury, mercury mixtures and mercury compounds, as well as the import, export, manufacture and supply of mercury-added products.        The Commencement Notice seeks to appoint December 1, 2021, as the ... Read more

The Competition Commission of India (CCI) receives a notice relating to the acquisition of certain shareholding in OFB Tech Private Limited by SVF II Orca (DE) LLC, under Green Channel and is deemed approved. The CCI received a notice relating to the acquisition of certain shareholding in OFB Tech Private Limited (Target) by SVF II Orca (DE) LLC (Acquirer), under Green Channel and is deemed approved. SVF II Orca (DE) LLC is a newly incorporated entity set up to make mid to long term financial investments in technology companies. It belongs to the SoftBank Group which is present in India ... Read more

Eisai Co., Ltd. announced today that Biogen (Nasdaq: BIIB) has disclosed, in its Q1 2021 Earnings Press Release issued on April 22, its current submission status of the Marketing Authorization Applications (MAA) for aducanumab, an investigational treatment for Alzheimer’s disease, in countries other than the United States, Japan, and in Europe which have been announced previously. In the first quarter of 2021 Biogen submitted a MAA to Ag?ncia Nacional de Vigil?ncia Sanit?ria (ANVISA) in Brazil for aducanumab an investigational treatment for Alzheimer’s disease. This application is currently in queue for review. Biogen also submitted MAAs for aducanumab to Health Canada, ... Read more